nuciferine has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XJ; Xie, JR; Zhou, G | 1 |
| Chen, BG; Guo, YX; Hu, ZH; Li, J; Li, QH; Ma, ZH; Sui, LP; Tang, YL; Zhao, YH | 1 |
2 other study(ies) available for nuciferine and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Nuciferine Inhibits Oral Squamous Cell Carcinoma Partially through Suppressing the STAT3 Signaling Pathway.
Topics: Animals; Aporphines; Cell Line, Tumor; Cell Proliferation; Humans; Mice; Mice, Nude; Mouth Neoplasms; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor | 2023 |
Tripartite Motif-Containing 44 is Involved in the Tumorigenesis of Laryngeal Squamous Cell Carcinoma, and its Expression is Downregulated by Nuciferine.
Topics: Animals; Aporphines; Carcinogenesis; Carrier Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Head and Neck Neoplasms; Intracellular Signaling Peptides and Proteins; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; Squamous Cell Carcinoma of Head and Neck; Toll-Like Receptor 4; Tripartite Motif Proteins | 2021 |